Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9AVR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,370
Award facts
- Contract value 100% obligated
- $16,369.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,369.88 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml units). This firm fixed-price, competitively awarded delivery order was issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement running through December 2026 that supports military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, ranging from specialty medications to vaccines and medical supplies supporting the Defense Health Agency and other government healthcare systems. Pulmozyme is a branded mucolytic agent commonly used in respiratory care, reflecting the company's role in supplying both specialty and standard pharmaceutical products to support military medical operations.
Quick answers
Who was awarded contract SPE2DR26F9AVR?
SPE2DR26F9AVR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F9AVR worth?
The government has obligated $16,370 on SPE2DR26F9AVR.
Is contract SPE2DR26F9AVR an order under another contract?
Yes. SPE2DR26F9AVR is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9AVR competed?
The extent of competition for SPE2DR26F9AVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award